Characterization of T‐DM1‐resistant breast cancer cells

• Main Authors: Juliette Sauveur (Author), Louise Conilh (Author), Sabine Beaumel (Author), Kamel Chettab (Author), Lars‐Petter Jordheim (Author), Eva‐Laure Matera (Author), Charles Dumontet (Author)
• Format: Book
• Published: Wiley, 2020-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract The development of targeted therapies has drastically improved the outcome of patients with different types of cancer. T‐DM1 (trastuzumab‐emtansine) is an antibody‐drug conjugate used for the treatment of HER2‐positive breast cancer combining the FDA approved mAb (monoclonal antibody) trast...